Dolby Laboratories, Inc. Financials

Market Capitalization $6.07 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	24.51
Forward PE	13.96
Price to Sales TTM	$4.55
Price to Book MRQ	$2.34
Enterprise to Revenue	4.06
Enterprise to EBITDA	14.90

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2025-09-26
Most Recent Quarter	2025-09-30
Profit Margin	18.90%
Operating Margin	11.66%
Return on Assets TTM	5.52%
Return on Equity TTM	10.02%

Income Statement

Revenue TTM	$1,349,129,984
Revenue per Share TTM	$14.07
Quarterly Revenue Growth	0.70%
Gross Profit TTM	$1,188,998,016
EBITDA	$393,570,000
Net Income to Common TTM	$255,018,000
Diluted EPS TTM	$2.62
Quarterly Earnings Growth YoY	-15.80%

Balance Sheet

Total Cash MRQ	$702,595,968
Total Cash per Share MRQ	$7.36
Total Debt MRQ	$
Total Debt to Equity MRQ	1.48
Current Ratio MRQ	3.17
Book Value per Share MRQ	$27.47

Cash Flow

Operating Cash Flow TTM	$472,198,016
Levered Free Cash Flow TTM	$408,661,760

DLB Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	95,462,661
Float Shares	60,171,577
Avg 10 Volume	621,790
Avg 30 Volume	None
Shares Short	2,886,456
Short Ratio	4.34
Short % of Shares	6.36%
% Held by Insiders	1.24%
% Held by Institutions	98.59%

Stock Price Summary

Beta	0.89
Fifty Two Week Low	$63.23
Fifty Two Week High	$89.66
Fifty Two Week Change	-22.97%
Day 50 MA	$66.46
Day 200 MA	$72.38

Dividends and Splits

Forward Annual Dividend Rate	$1.44
Forward Annual Dividend Yield	2.27%
Trailing Annual Dividend Rate	$1.35
Trailing Annual Dividend Yield	2.12%
Payout Ratio	50.38%
Dividend Date	2025-12-10
Ex Dividend Date	2025-12-02
Last Split Factor
Last Split Date